Fresenius Medical Care has launched Rephoren for hyperphosphataemia associated with chronic renal impairment in adult patients on dialysis.

Rephoren (calcium acetate and magnesium carbonate) should be taken with meals and swallowed whole to achieve the maximum phosphate binding effect.

The recommended dose is three to 10 tablets daily in divided doses, dependent on the serum phosphate level (maximum 12 tablets daily).

View Rephoren drug record

Further information: Fresenius Medical Care

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in